Kalbe Farma KLBF IJ -Buy- Transforming the brand
Consumer health is a very crucial division for KLBF, as it possesses the highest margin,
Consumer Durables SH JW SC NY 1.8K 2nd Feb, 2026
|
We believe
consumer sector is the least regulated industry in Indonesia, making it
relatively more predictable than other sectors currently. A pick-up in
government spending in the coming years on priority programs such as free
school meals, agriculture, and village cooperatives will keep flowing mostly
to lower-tier cities and rural areas, in our view. That said, we project
stronger consumption by the low-income segment to drive Indonesia consumer
companies’ EBIT growth from +4.7% y-y in FY25F to +14% y-y FY26F. The overall
valuation of companies under our coverage currently hovers around 13x FY26F
P/E (-1 SD to five-year-mean), which suggests relatively low downside risk,
although Indonesian consumer companies still lag their regional peers in
terms of valuation (see Fig. 2). We cherry-pick the stocks based
on our total shareholder return (TSR) framework (read: Evaluating stocks through
a TSR framework), focusing
on metrics such as superior EPS growth, higher dividend-paying potential, and
valuation. In our view, superior EPS growth and higher dividend-paying
potential can be attributed to a company’s ability to stay relevant with
evolving consumption trends, enabling them to gain market share and to grow
faster than the industry. Our top picks in the Indonesia consumer sector are
(in order of preference): Mayora Indah (MYOR IJ, Buy) >
Kalbe Farma (KLBF IJ, Buy) > Cisarua Mountain Dairy (CMRY IJ, Buy) > Ultrajaya
(ULTJ IJ, Buy) > Mulia Boga Raya (KEJU IJ, Buy) > Sumber Alfaria
Trijaya (AMRT IJ, Buy) > Midi Utama Indonesia (MIDI IJ, Buy) > Indofood
CBP (ICBP IJ, Buy) > Wismilak Inti Makmur (WIIM IJ, Buy) > Daya
Intiguna Yasa (MDIY IJ, Buy) > Erajaya Swasembada (ERAA IJ, Buy) > MAP
Aktif (MAPA IJ, Buy) > Mitra Adiperkasa (MAPI IJ, Buy) > H.M. Sampoerna
(HMSP IJ, Buy) > Sariguna Primatirta (CLEO IJ, Buy) > Sidomuncul
(SIDO IJ, Buy) > Multi Bintang (MLBI IJ, Buy) > Indofood (INDF IJ, Buy)
> Aspirasi Hidup Indonesia (ACES IJ, Buy) > Nippon Indosari Corpindo
(ROTI IJ, Neutral) > Matahari Department Store (LPPF IJ, Reduce) >
Ramayana Lestari Sentosa (RALS IJ, Reduce) > Gudang Garam (GGRM IJ,
Reduce) > Unilever Indonesia (UNVR IJ, Reduce). Product
relevance We highlight two key consumer trends in Indonesia
currently: 1) government stimulus driving growing consumption in lower-tier
and rural areas; and 2) middle-income segment’s downtrading consumption pattern in big cities. We
expect companies that can adapt to and capture these trends to outperform
peers. For instance, higher disposable income in the low-income segment may
boost consumption on affordable luxury discretionary products such as higher quality
of snacks, confectioneries, and cosmetics – MYOR’s export-quality
products and competitive pricing advantage make it stand out in the low-end
consumption segment, in our view, as illustrated by its historically strong
domestic sales growth. In the middle-income segment, we believe consumers now
increasingly prefer to cook more at home and have cut back on dining out to
save money – CMRY with its Kanzler brand (perceived as a
practical high-quality frozen food brand) appears to be well positioned to
capture demand from the middle-income segment of consumers that want to have
better quality of food ingredients – this is evident from Kanzler’s superior
sales growth relative to peers. We believe KEJU is riding on the
growing baking-at-home trend, given its larger product portfolio vs
competitors. Through creative marketing and trendy product packaging, KLBF’s energy
drink attracts younger consumers who seek cheaper replacement for energy
booster beverage and ready-to-drink coffee. Pricing
relevance There is limited room to raise selling prices in
Indonesia, in our view. We estimate that over FY22-25F, overall Indonesia
FMCG product prices witnessed a significant rise, by +30% – much higher than
the cumulative nominal minimum wage increase of +16% during the same period.
On top of that, low-income to affluent consumers have now increasingly become
more selective in their choices, while looking for good quality with cheaper
prices. Against this backdrop, we believe MYOR can expand its market share further,
due to its high quality (evidenced by its significant export volumes) and
relatively cheap prices vs multinational brands. KEJU has also continuously
expanded its market share, given its comparable quality and substantially
cheaper price points vs multinational brands such as Kraft (KHC US, Not
rated). In the cigarettes space, WIIM can capture demand from consumers who
seek good quality of cigarettes with cheaper prices than tier-1 players. Channel
relevance We expect FMCG sales growth in general trade (GT) to
continue to outperform modern trade (MT) as: 1) much of the government
stimulus will likely flow to lower-tier cities and rural areas, which we
believe can be captured by the GT channel due to its proximity to customers;
and 2) consumers in big cities continue to downtrade from bulk to sachet
products, which is more available in GT. Therefore, FMCG firms with wide
distribution networks in GT such as MYOR and ICBP could see higher demand.
And this also offers opportunity for several FMCG firms such as CMRY, KEJU,
and KLBF to aggressively expand their reach in GT. In the retailer space, we
also believe MDIY is in a good position to capture potential rising demand in
lower-tier cities.
|
|
|
INVESTMENT RATINGS
A rating of ‘Buy’, indicates that the analyst expects the stock to outperform the Benchmark over the next 12 months. A rating of ‘Neutral’, indicates that the analyst expects the stock to perform in line with the Benchmark over the next 12 months. A rating of ‘Reduce’, indicates that the analyst expects the stock to underperform the Benchmark over the next 12 months. A rating of ‘Suspended’, indicates that the rating, target price, and estimates have been suspended temporarily to comply with applicable regulations and/or firm policies. Securities and/or companies that are labelled as ‘Not Rated’ or ‘No Rating’ are not in regular research coverage. Benchmark is Indonesia Composite Index (‘IDX Composite’). A ‘Target Price’, if discussed, indicates the analyst’s forecast for the share price with a 12-month time horizon, reflecting in part of the analyst’s estimates for the company’s earnings, and may be impeded by general market and macroeconomic trends, and by other risks related to the company or the market in general.
GENERAL DISCLOSURE/DISCLAIMER
This report is prepared by PT Verdhana Sekuritas Indonesia (“PTVSI”) a securities company registered in Indonesia, supervised by Indonesia Financial Services Authority (OJK) and a member of the Indonesia Stock Exchange (IDX).
This report is intended for client of PTVSI only and no part of this document may be (i) copied, photocopied or duplicated in any form or by any means or (ii) redistributed without the prior written consent of PTVSI.
The research set out in this report is based on information obtained from sources believed to be reliable, but PTVSI do not make any representation or warranty as to its accuracy, completeness or correctness. The information in this report is subject to change without notice, its accuracy is not guaranteed, it may be incomplete or condensed and it may not contain all material information concerning the company (or companies) referred to in this report. Any information, valuations, opinions, estimates, forecasts, ratings or targets herein constitutes a judgment as of the date of this report is published, and there is no assurance that future results or events will be consistent.
This report is not to be construed as an offer or a solicitation of an offer to buy or sell any securities or financial products. PTVSI and its associates, its directors, and/or its employees may from time to time have interests in the securities mentioned in this report or it may or will engage in any securities transaction or other capital market services for the company (companies) mentioned herein.
ANALYST CERTIFICATION
The research analyst primarily responsible for the content of this report and certifies that the views about the companies including their securities expressed in this report accurately reflect his/her personal views. The analyst also certifies that no part of his/her compensation was, is, or will be, directly, or indirectly, related to specific recommendations or views expressed in this report.
RESTRICTIONS ON DISTRIBUTION
By accepting this report, the recipient hereof represents and warrants that you are entitled to receive such report in accordance with the restrictions and agrees to be bound by the limitations contained herein. Neither this report nor any copy hereof may be distributed except in compliance with applicable Indonesian capital market laws and regulations.
Sandy Ham (sandy.ham@verdhana.id)
Jody Wijaya (jody.wijaya@verdhana.id)
Samuel Christian (samuel.christian@verdhana.id)
Nayla Yasmin (nayla.yasmin@verdhana.id)
saya
Consumer health is a very crucial division for KLBF, as it possesses the highest margin,
Based on our survey of distributors and wholesalers, MYOR's domestic sales may have grown
As mentioned in our previous reports, Indonesia local FMCG companies have
Our analysis of FMCG and retail sales data of companies we track across Indonesia suggests that Sulawesi,
AMRT has consistently outperformed its FMCG peers in terms of sales growth over the past decade
Indonesia is a young nation (110mn population are below 40yrs, based on BPS) as well as social media-savvy (th